Olympus Co. (OTCMKTS:OCPNY) – Investment analysts at Jefferies Financial Group issued their Q3 2021 EPS estimates for Olympus in a note issued to investors on Tuesday, January 12th. Jefferies Financial Group analyst M. Nakanomyo expects that the company will earn $0.07 per share for the quarter. Jefferies Financial Group also issued estimates for Olympus’ Q4 2021 earnings at ($0.02) EPS and FY2023 earnings at $0.77 EPS.
Separately, The Goldman Sachs Group assumed coverage on Olympus in a research report on Monday. They set a “conviction-buy” rating for the company.
Olympus Company Profile
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services.
Read More: Options Trading – What is a Straddle?
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.